Form 4: Herbalife Director Celine Del Genes Reports Acquisition of Restricted Stock Units

Director Celine Del Genes reports acquisition of 21,857 restricted stock units in Herbalife Ltd.

Summary

• Celine Del Genes, a director of Herbalife Ltd., reported the acquisition of 21,857 restricted stock units (RSUs) on May 2, 2025.
• The RSUs were granted under the Herbalife Ltd. 2023 Amended and Restated 2023 Stock Incentive Plan.
• These RSUs will vest 100% on April 15, 2026, contingent upon continued service on the Issuer's Board of Directors.
• Following the transaction, Del Genes directly owns 55,818 shares of Herbalife common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction of granting stock-based compensation. It indicates alignment of interests between the director and the company's shareholders.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future.

Future Outlook

The vesting of the RSUs is contingent upon continued service on the Issuer's Board of Directors through April 15, 2026.

Industry Context

This filing is a routine disclosure of stock-based compensation to a company director, a common practice in publicly traded companies to align the interests of management and shareholders.

Stakeholder Impact

• The granting of RSUs aligns the director's interests with those of the shareholders, incentivizing them to work towards the long-term success of the company.

Key Dates

Keywords

Herbalife, Director, RSUs, Stock Incentive Plan, Beneficial Ownership, Securities, HLF, Del Genes